GMED - Earnings call transcript Q4 2017

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Good day ladies and gentlemen and welcome to the Globus Medical Fourth Quarter and Full Year 2017 Earnings Call. At this time all participants are on a listen only mode. Later we will conduct the question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, this conference call maybe recorded. I will now like to introduce your host for today's conference, Vice President of Investor Relations, Mr. Kearns. Brian

begin. may You

Brian Kearns

much, today. thank very being everyone, with us Dmitry, you you, and for Thank

call Globus CFO; website Globus today's review through Scavilla, and Joining the from Paul, at is Senior CEO; Dave David section via Vice www.globusmedical.com. Dan being Demski, Investor made President webcast, Chairman. Relations Medical and Executive Anthony available President; Medical Williams, This will accessible be the of

or during may remind you considered that of this Before review begin, made are let me statements. we be the forward-looking some statements

Our for filings in could projected differ XX-K certain Exchange the Form to and XXXX those that our with Commission any fiscal forward-looking subsequent cause factors and results from year our statements actual the made Securities materially identify today.

available undertake result do website. are Our future on information our to any a as SEC or not filings, of statements new events forward-looking or We the update including developments. XX-K,

Our most David most over the are directly website. call that, financial together CEO. with Principles financial these for discussion calculated of Globus pertinent be include on not section GAAP the the with not should release also to additional available non-GAAP provide business accordance Generally I'll to be our turn to the considered financial to Medical GAAP. the should and are With read that GAAP information our or performance. certain the measures and today Reconciliations financial directly in measures. measures press the will comparable These Accepted measures now We accompanying Accounting in replacement non-GAAP measures comparable Demski, schedules Investor believe Relations

David Demski

was increase of XX.X% for Worldwide the over and the Brian, fourth $XXX XXXX. quarter everyone. you, quarter Thank XXXX of of fourth afternoon, an million, revenue good

to increase XX.X% year, for full million. XXXX. quarter an the was For revenues EPS XX.X% $X.XX over of fourth the of share per quarter Non-GAAP increased the fourth $XXX

a in acquisition to XXX% increased of year, as we full the to EPS strong quarter the was achieved Revenue sectors completed of was final business result system. non-GAAP growing attributable combined we of quarter revenue our assets quarter in trend fourth continued third a XXXX. and by its XXXX. combination in organic, U.S. quarter with ExcelsiusGPS the fourth the in X.X% share. exceptional performance fourth the our earnings $X.XX of implant by The quarter the over XX.X% revenue Alphatec's growth recent per international all of For first growth business of of The the

XXXX. been the third You five will the recall have that out quarters, in rates quarter growth of past accelerating for having bottomed year-over-year after

QUARTEX was and and of new from Globus seeing results robust, progress be we We MIS in in medical by leader the as fusion fixation record introductions the behind spine. technology us. our to recent U.S. our year for our largely integrated our continue system. a to our additions are due to this cervical product screws, position continued though interest the XXXX platform, CREO recruiting cervical posterior sales force strong Growth in coalition easy led by encouraged remains from are part business comps even now strong

begin compared impact Our as growth business deliver fourth implant are by off. international in growing manpower quarter of to we quarter results pay fourth exceptional starting The to to increased outstanding business XX.X% to spine see delivered continues Japanese and the sets investments the in XXXX. the of

improvements plans were of Globus markets were several international The market the unique introduce remainder introduction continue in this quarter. in and as aggressive Branded to a year, We seen technology. XXXX expect significant hiring of expandable we'll our throughout the including the combined Technology also in we experienced strong business have our growth turnaround from first Operational working quarter largely in markets. of a quarter XXXX full was that the after The business. and These supply Alphatec were inventory some transition quarter fourth XXXX from impact of the resolved through soft we fourth issues and quarter the in first the with limited of XXXX. very the issues for sales acquisition,

achieved progress, business we pleased the the fourth of in term, for the sustainable While growth we the impact are our not of growth first issues particularly reverses. in of this appropriate quarter Alphatec rate as are is likely with near-term. short operating quarter in in rates the the the High-single-digit expectations segment XXXX more our

and we navigation calls, seen tremendous surgeons our ExcelsiusGPS we have prior have enthusiasms stated system. in As by for robotics

clearance. That These resulted these interest and quarter. the the Systems pleased As strong Peroscopy. by the period only following design have short product. deliver combines could more and not on significant team FDA single in a of Interop of elegant in a work imaging an the a the I results revenue combined CT fourth and exhibited capital Preop Robotic three CT, technology with is robotics integration platform implant with full and to time in modalities, that reminder, in supports generated Implant work interest features this teams and such our navigation different Globus be flow

done In remain in turning purchase job leader burgeoning accounts in addition, and and the support installations teams these tremendous that implant surgery the spine is done this Globus Robotic transform technology. intends early way this potential our has into a clinical the the have endeavor. technology of to to programs robotics

encouraging. very are results early Our

have our systems now trauma, XX that the we to clearance have we systems. received on core to that for identified FDA we Moving announce are pleased as

have basis doing on we with noted last system. one begun our a call, cases we limited As in

fronts. progress the report fully these inventory on Our happy focus systems all both building is and launch sales world-class required recruiting a to now I'm to great force.

team first to we the We we systems the we feedback we opportunity. the QX. in with and have further potential way, surgeon expect market this advanced all clearly quality of Orthopedic doing representatives we systems is our of highly received same advanced launch of Based sales patient throughout in care Furthermore, the to this joined the last of what Association in to and patient at have the successful on introduce full spine. the fall, launching and solutions care endorsement quarter quantity Trauma skilled who begin are new believe

growth XXXX to to by and in the in that revenues expect implant maintain and our world. to the signs will in the trends we to focused we recent other parts XXXX trauma our have the remain robotics on on spinal we continue for we look on development, early outstanding remain recruiting We of performance significant impact in U.S. sales a are and we Japan technology Internationally, XXXX. forward stage of launches, business as anticipate As turnaround product bullish XXXX new the expect in growth encouraged set in our

EPS robotic breakeven. per fourth and non-GAAP delivered basis technology share XX.X% quarter emerging of quarter as to over drag from $X.XX improvement fourth from of a $X.XX the $X.XX Our was Much improvement is for is we strong EPS to sales XXXX. the this approximately on due non-GAAP in the negative

trauma we our investments be investments profit in commercialization with and a see XXXX, contribution are in increases expect combined growth it from we XXXX Given making will for plant emerging in significant before the we robotics technologies.

the business more of to tax see contribution As large outline the Dan to the to path, XXXX. of but the will try earnings legislation our the into anticipated pleased portion we were very our reform savings in call, expect reinvest we also in a segment

year fourth from smoothly has the for David credit CEO the an in of the very Globus change was which gone transition to very a outstanding performance Our me to significant we significant quarter leadership Medical, with that's of team experiencing. over the technology a to passionate all world. way foray is are robotic dedicated into milestone in strong field have a crossed Furthermore, and and employees success place our are commercial we the the closeout

Our lot XX innovation implant technology even our call in remains of the last have and field years I now stage future set the journey looks a vibrant and the new we over into we to brighter. will accomplished for Dan. turn Well, trauma. the spinal have

Daniel Scavilla

and Thanks, Dave, everyone. good afternoon,

one-time XX.X% fully with GAAP reported of free and reform adjusted EBITDA of was QX was per day strong million one-time XX.X% by share country. the million including growing earnings income of Non-GAAP of the million in of flow. improvements flow. robot diluted a by with reform free XX.X% GAAP reported Excelsius Non-GAAP throughout financials one sales $XXX.X were international hospitals million a the selling diluted tax including non-GAAP and year $XXX Japan of income uptake adjusted business, growing per $XX non-GAAP pleased charge Full $XX less XXXX. $XXX.X strong and tax cash was $XXX.X million $X.XX income million as as continued U.S. are net of in XX.X% fully share QX million net delivering net in the of driven million. net income with from and million. EBITDA $XX.X sales resulting million $X.XX delivering charge $XX.X were cash growth $XXX significant earnings and We $XX.X

were XXXX. sales than $XXX quarter XX.X% million U.S. sales, on Focusing for higher the QX

International improvements and stronger rep continue We business structural launch have coupled business improvements Excelsius to the sequential robot recruiting we our sales with in to the we the made acceleration growth U.S. resulted and through in constant or were core international growing continued XX.X% reported XX.X% markets the currency. believe momentum drive will in as Gains increases were sales business. momentum key continued in Japan, penetration achieved the year-over-year in of that from and in competitive for other market the see organic XXXX. in quarter improved million, $XX spine growth U.S. distributor

revenue year-over-year the to the growth attributable comp. of QX XXXX lower Some was

the was first full limited during of acquisition transition that supply were that some markets. the activities XXXX QX and and working quarter mentioned, Dave period in inventory through As Alphatec we sales

some fusion CREO Disruptive once for $XX.X integrated were sales with in XX.X% increases international Alphatec growth Innovative sales in Alphatec. As distributor received the CREO sales and $XX.X MIS spacers, result, technology business. inventory Biologics. expandable orders Excelsius XXXX by QX driven were shipped or or was growth million million and QUARTEX, a from and X.X% were enough quarter

that expenses spine SG&A or related XX.X% grew quarter R&D charge, versus in the Full expansion XXXX be reform or lives in QX charges cases increase the is and in in commercial contained tax XXXX, XX.X%, the a QX income both investments our for while QX Robotic to million the $XX.X XXXX', XX.X% building margins, $XX.X $XX compared fourth gross development which in the QX XXXX was for by remains and including tax charges million XXXX extended QX a depreciation strong for XXXX'. year approximately and earnings XXXX basis quarter sales, QX our GAAP asset million XXXX, to Japanese was $X gross the XX.X%, year, were negatively expense, tax profit of at points. excluding from to prior recorded impacting XX.X% profit and years, million profit QX sales In QX and X.X% one-time re-measurement comparability. one-time of compared points emerging Research the or instruments compared XX.X% scrap to projected and increased of we the technologies gross operational primarily basis QX one-time spine. XXXX. QX three from There XXXX, at QX force. expenses were one-time of year in net million repatriation. gain for for P&L, was sales XX.X% force full The XXX impact $XX multiyear Turning year-on-year depreciable as forced gross million to rate teams we profit gross U.S. fourth acquisition a had XX%. deferred approximately QX were in X% or the $XX.X and investments this by XXX driven XXXX XXXX rest to charge five foreign

of XXXX approximately the Excluding XXXX for resulted in We legal was QX stock in structure, rate approximately domestic QX effective project XX%. for effective this impact $X.XX, flow by our tax and the fourth in XXXX. increased is XXXX year quarter since effective provided QX and reflecting per XX.X% was and compensation approximately of technology quarter gain emerging $XXX was in million, from regulations XX.X%, per points accounting by million, robotic cash adoption free. sales was be tax from million, XXXX operating $XX.X Adjusted debt negatively GAAP tax year XXXX. earnings was for offset share rate basis strong with the XX.X%, EBITDA million. XXXX. partially was adjustments in technologies rate and QX $XXX.X versus of $XX.X an by XXXX million, $XXX.X charge, activities foreign free approximately year-end Full $X.XX reaffirms and cash was of XXXX with coupled income non-GAAP equivalents investments ended negative QX gains share reorganization income activities XX.X%, diluted flow We guidance cash non-GAAP million, Full cash adjusted and in share less The securities, XXX tax $X.XX. QX the than and was The million, and credits for the $X.XX company the of and has $XX.X net company to to operating spine the cash one-time of QX net emerging non-GAAP compared XX%. XXXX, from in earnings were $XX.X provisions. year marketable $X.XX, the $XXX.X per $X.XX remains free year EPS net earnings sales were million diluted full net cash, EBITDA was GAAP projected diluted full

for will call We now open questions. the

Operator

comes Instruction] from [Operator first you. Biegelsen Our question Thank Fargo. Larry Wells with

proceed. may You

Larry Biegelsen

the QX, guidance, with and thing you on for XXXX, cadence couple anything, talk follow-ups. in of did a the taking I international bit deceleration you you through XXXX, the softer growth Hey, quarter. that guys. guiding so other about called X% organic Thanks. are XX% reason are Thanks can is you a little growth a and about you to the any to QX, expect congratulations X% why from and QX start let good a but XX% is only questions Dan to there have be to just me in expect you you expecting for from the out

Daniel Scavilla

I Larry. things there couple this. Thanks, say is a with would

would First X% market that looking between is, at triangulate spine X%. you're to a everyone to probably

to leader just that times our market. into approach. walk it's between I we two is beginning think with that to declaring and of good think as and natural us So, three way I for grow the It a the year, are step core a

international with think strong to above having necessarily just a quarter and as out not continue that quarter In we're factored robotics And addition, a forward into well also rate. gets well but called on Dave prudent that as growth comp fourth we layering out we you is had emerging belt primarily know one the again lunch I under market top different mentioned, the and with as of technologies growth also put move. our that and

Larry Biegelsen

in could technologies, follow-up, on helpful. are for And feedback That's just field. guys And are for some assuming you David, you think XXXX robots guidance? the hearing you I the the primarily too? what then who provide What people of or type are What's used from emerging robot the these that implants physicians most taking or the guys. loyalist haven't the that feature for are gravitating accounts surgeons buying typically past? attractive are Globus questions, Thanks or Globus qualitative the

David Demski

to going handed I'm Larry, Hey to first the part Dave. over then answer

we split So, of not guidance. have out parts our individual

there overachieve some think and short but different get the XXX fall some of our combinations there. we areas to all within are getting will have we total may ranges and think I many in

to guide to we're number. going So, those achieve leavers company and one as total appropriately use that

Larry Biegelsen

And the… David on

David Demski

today question installations in that we've part second gratifying really it's getting. me very we're been of the find what on of attractive, take the your most terms importantly I and gone a the factors, in made, single let they your platform. navigation there is response it's Yeah, combination most terms It's of I to question the think about think a of probably of integration And smoothly. robotics

we've elegant integrated I the I imaging the us it case. the they workflow, imaging the made is any surgeons way normally And in don't think them to investments emplace. Globus think the way appreciate, from or and different hospitals of implant equipment do enables terms finally accommodate have with disrupt they very modalities the

as we're to then focus the combination a to past we this point. as of that part seeing within appeal. factors the Globus had up your from accounts don't I interest mixed has that think well both and business pretty haven't question, it's those second it's of And this

we've So, it we're focus use greatest haven't get time this does who well, some to to prior been starting a know. to, interest and

Larry Biegelsen

taking the for Thanks guys. questions

David Demski

Larry. Thanks,

Operator

our Jonathan And Demchick from next comes with Morgan Stanley. question

sir. You may proceed,

Jonathan Demchick

to wanted some really Larry's question. the Excelsius. that taking the of for And accounts thanks profile purchased of the a Hello. bit on I on follow-up questions the

that really account. mentioned you've I and those of implants to between of and terms it's guess other accounts loyalist focus seen Globus one more the was the split kind can you shifting another as from follow-up, in that but system, thanks. really And optimize now trying Specifically, people what sales through I I they quick that towards been whole they using there robot? Globus on are have

David Demski

The these more So, much Jon, we're efficiently use system almost implants exclusive just seeing on those pedicle cases. with screws Globus screws. works of for

Jonathan Demchick

are wanted where revenue or emerging bit next to going products sales helpful? the of more that made Do and just follow-up million you getting initially going this place And about the added Thanks. this to platform that going the on are investments ground? are $XX predominantly be into any trauma year, Thank be off to Is these there added technology added focused? think Is a for is there the during to on be you expense you. marketing, there? force clarity would that

Daniel Scavilla

Jon, seeing trauma, that product at are we at continuing in the I And board of to the in to force meet there our on we're heavily in of and force point. sales the We're this demand expanding looking some enhance across navigation can the follow-on then the as well. capital business, imaging invest platform. sales up to it's terms then take And robotics current products for the piece ramping the that development market. we're we're

Jonathan Demchick

Thank much. you very

Daniel Scavilla

Sure.

Operator

Zimmerman question from next Ryan comes with And your BTIG.

proceed. may You

Ryan Zimmerman

me, hear Great, can okay? you

David Demski

Yes.

Ryan Zimmerman

you. Thank

in rate? demand well. have bit some quarter, at the to then think we want was fantastic what point, the cycle early the should And the think and throw how and I of to that just just ups little you. follow on was robotics water looks but the Thank up So well. couple of a sales there pent-up Not start we this robotics questions a And about what commercialization. run follow should kind as the of like as

David Demski

asking. for thanks Ryan Hey

fourth of that we core So, first for stick see the as that things, out effect couple do. quarter in you and quarter fourth an hockey something all And of in experience Spine certainly differently QX. we is saw normally come

the thinking quarter hospitals we occurs that's XX% the like about and things well well. on think see think cycles normal. is What I demand to of in financial fourth as based So, look we're we as that capital

quarter forward. take that So, we I appropriate roll performance know fourth if to don't that to

I think And have through. we is think to that think true new, demand up certainly some that it some process pent-up But is don't what there there. here nonetheless open interest the pent some of there think you would what was type items. seasonality. I measure I was accurate a just we say those

Ryan Zimmerman

curious Appreciate up given competitive hiring of that color greenfield to you And about should may about your the hire have for of And a reps think How you going are reps. comments end challenge follow territories on your just continue comments XXXX that. over your really really on XXXX. had I the dynamic guys the reps. that then some robust mean we kind splitting? sales at in potentially existing Those types opportunities of to XXXX. and and

David Demski

question. great it's shares X Now in we're the that in mind Keep U.S.

for lot And to a can reps. of lot there really that of into we start is into. before own our bumping get us do we so, penetration A still territory

a convert or where where us And into X a it shares the lot the drive continue market. a share so higher occur to and of but and gives take to of may fact somewhere, certainly opportunity few those

Ryan Zimmerman

Thank taking you the for very questions. much

Operator

from next question Richard comes with Newitter our Partners. Leerink And

may begin. You

Richard Newitter

quarter. and taking on the for questions thanks the Hi, congrats

XXXX. a years you, at of you sales a one Analyst first few So, Day for Dave, maybe billion at the kind $X in beyond ago, about talked your

the to about about talk about $XXX You get with between robotics And time. just a the emerging as you would going mark? be of combined you the then sure contribution that side, weren't the Alphatec you trauma XX% about Any revenue robot business a wondering what did just tech kind emerging aggregate of trauma XX% that the approach $X contemplating million. now being at changes about OUS. clearly I'm a and commercial. in And expect international contribution on or that on technologies in billion sales. point kind I'm view to

So, Thanks. any be updates there helpful. would

David Demski

Rich. Thanks

But think the revise haven't gone back we're We really don't there. too projections I far off. and

organic emerging still interim technology account for less think in we're growth of period. think optimal the the been didn't range has numbers. Alphatec, low than I we And within hitting while I our

I and the we those in update ballpark, at some later numbers So, maybe then. think be still looking will doing plan to it that year are probably this on

Richard Newitter

That's more, balance at looking under sheet just And are Brian on here. XXX, one just the the then cash or Okay. million of opportunities. you've $XXX I helpful. there and constantly the team know maybe got

where when you can sense think to help deployed? give and Thanks. needs just you of that see might us as where capital externally? the So portfolio kind any we most the potentially And

Daniel Scavilla

our Yeah. execution robotics organization, we be XXXX, what on we it's think two as Thanks in at to And opportunities. we're actually I refer with bandwidth need year, an in us and front where that trauma those an deployed to as of we Rich. I look going as is opportunity the with have to

don't at we're all see year our take looking But a ourselves for basically. things anything themselves this is and present of bet look something think at it. this significant I always course doing I if very as We opportunistic best So, year. at we'll on

Richard Newitter

thanks. Okay,

Operator

Blair. next with question comes William from our And Krum Kaila

may You proceed.

Kaila Krum

for our Hey, taking questions. guys. Thanks

So, I couple off, guess first on robotics. a

us - et detail when pipeline extended any I potential trauma back off should first we I I on about help number or robotic think understand you this can realty accounts cetera? many the quarter, about the then into think platform that guess the of And into those you you but systems. scaling and you second, the how came how system fill give systems augmented in mean into you can

Daniel Scavilla

thanks Yes, Kaila.

right for out or get revenue, enough in will the competitive of And We year to terms early the terms some highly detail our intention reasons. competitive but information with year begin to not It's you you now. to ASPs next on in have it's of have taking into things tried late to figure where this level probably or granular just market are pipeline into platform. units give we sharing the we expanding in our and that

Kaila Krum

Okay, the but I out really those that I just contributors, guys quarter, handful mean of you growth. as those are year. parse specific the think durable And spine you kind can that's helpful. performance drivers just strong into talked quarter drivers U.S. a we how about then guess of implant in this in and Thanks. about

David Demski

thanks mean sequentially and would rolling called them inroads about I Kaila. grow, newer launches I concern Hey, making screws, we I products out through I expendables XXXX, and we don't think every going it's bag really feel into but be had et really I several through we continuing to improvements XXXX market, as pedicle those would see are that and with some XXXX addressing strong. into of durable, providing is going well, like area continue how not product doing through would we how continue biologics have to that anything you of there other the think the products, retain that the cetera. we are items recruit, continues out the just to we occurred we We penetrating then tell in cycling,

Kaila Krum

guys. Thanks,

Operator

Our Merrill Lynch. Hopkins next Bob with of from question comes America Bank

You may proceed.

Unidentified Analyst

Hi. Bob. is Travis for Good afternoon. on This [ph]

million trying trauma for your to to $XX business ways for grows assuming U.S. $XX to the we $XX your I we XXXX about? the mid-single-digits scenarios just the think more million of are low single-digits, you're various we million inflation of is talked ballpark getting that one robot, $X guidance are you thinking am So, U.S. are million of a in to high and what double-digits,

David Demski

in type or you carried say to year, that's thing modeling things story think One the but those we are of part trauma wouldn't plan it think wouldn't I'd part are investing bigger Yeah, this are on of we are more is with I a with we points some second a make hiring keep close reasonably away you folks, the guidance year, right onward, I XXXX the Travis. think of mind get launching. now. towards I I on the will I it anything of board get

Unidentified Analyst

you helpful. performance, for program. this and some that's of reps some on new the Okay, that, hiring the put about development to of talk And year you reps plans that your can also

Daniel Scavilla

Sure.

stages so with plans we're the happy folks record classroom learning, the early through in And then in spinal are have as we into we exceed but we still are happy their just in are area program, hiring terms the on their as we the of XXXX, continue that the program, some development we it's be Our set to active put way to implants. well starting in them they that with are territories. experiential to now progressing the and

it's too now. be to little they're right are effective signs going but territories, early positive say whether So, all to very those in

Unidentified Analyst

Okay, selling XXXX, thinking the cadence and then about for are XXXX? there any day differences in

David Demski

with split the always through take for we a overall -quarterly have you model. as but don't There exact and that extra I me the day take now, is offline one look year,

Unidentified Analyst

Okay, great. That's all I had.

Operator

And comes with Steve from our question Oppenheimer. Lichtman next

You may proceed.

Steve Lichtman

Hi, Thanks. guys.

the the ground. the market any Just that potential field seeing on on overall, new why of us thoughts from breakout terms wonder sluggishness have in of to things from heard that they continue anything updated the any if you've been heard for we you've in

David Demski

mind saying changeover Do anything think Steve. all the I to I you, anything and we taker at Thanks, years, look that drive X but to a tell we in are the and to would we out market get am Keep forward. regardless chance out will looking again some have capture at we looking make between of at us sales X% and talk X%, I and don't more concrete not few and being have to investors share public assign go and just or to we're plan we share actual X%, conferences us to some reported in if share, we've X% you talk don't to move we particular forward. that and about for lies healthcare and call this push more as heard a the the

Steve Lichtman

little drivers a there? are Dan mentioned I Okay. mix in be be that Thanks. the what or you down bit other would gross that international think And are would XXXX, is why margin

Daniel Scavilla

Thanks gets say and to approach just modeling U.S. international conservative growth give we are look continued and that's mid-XXs an is price in rationale is and to just I always tool am as we things. that. stronger you as for it, reasonable a Biologics then in I there One I pressure, approach use going some asking. overall going think There declare but beats a to go business couple with coupled in that guidance, and XXXX. to I'd some how price enter works that down into so see

Steve Lichtman

terms just out Thanks. quarter get when maybe in be think of in yield to how the And trauma player? needs you to few bigger go the what to and launch couple sales thing the second force bigger a ultimately the are to then big of how you broader years your lastly compete thoughts against

David Demski

Yes, a share market Steve our so know we're and it's we the is to account, as the match graphically really were number that head-to-head leader, investment. with but need are to of so significant not to them we plan we by be we going prepared to tradition, compete we reps up higher, with account

Steve Lichtman

Thanks. Okay, got it.

Operator

O'Brien Matt question our Piper with And next from comes Jaffray.

proceed. may You

Unidentified Analyst

question so with [ph] for on far on quick the is Will going the we to what for far one as move then platform robot, cetera. questions. forward know et should how think regarding taking cases there versus patient thanks as I your are the specifically you've Excelsius go that I DeJohnette Matt, But guess for versus in terms the of surgeons this outpatient certain strategy. are Hi, of Japan. seen using then market And complex that and types about I'll

David Demski

with lateral, It's question. DGEN, open its out the and the system in performed well - that tested its early The of the seeing variety the aspect. the and also versatility paces we're we're surgeon's surprising it seeing the posterior cases shows through for thanks put MIS, it every days Well, to form been and really willingness here.

Unidentified Analyst

those in far products know Thanks there out as of new what and hear. to great you expect as from lot. type a That's registering Japan And products do contribution with you where new XXXX? you the

Anthony Williams

Anthony. is this Hey, Will,

break aren't We onto think to the get we and that mentioned set then are maybe we government in additional there today incremental not technologies opportunity that pricing across fairly dozen pretty got so contribution more ones pricing and so systems. is some Japan our uniform expect as systems Dave advanced of to our at will in that that existing approved selling and they we've to to half from customers market using a expendable's the get two, another two are we being gotten few we then Globus two we've be. as as Initially by slay the or premium additional that process registered are those it's this have prepared products but switch and that those so do it in a our are out to think in we Japan be drive the point of able that is incremental is because So, existing contribution we from we submitted. revenue a the nominal revenue products be of what are products call

Unidentified Analyst

Okay, think then should that are asked new just growth? last XXXX driving in question, that's geographies, in about any fair. we there other you terms so one And of

Anthony Williams

at markets I those our not and continue to have Alphatec in have beyond both would international think core the borders. think that from plans take us acquisition. currently where I those would we any site don't the penetrate go or this we point

Unidentified Analyst

much. you Thank Great. very

Operator

our Barclays. next comes Lee [ph] And with from question Young

You may proceed.

Unidentified Analyst

new you order far, surgeons the to hospital about the compares guys in Hey, how system get expectation of place how maybe my utilization many maybe and about also just so by rates taking approved from that each talk can account admins? the needed guess first internal questions. your on are robotic question the I to talk

David Demski

that make surgeon spine to one depends the And certainly hospital, and them. of in do prepared with adoption already of we're terms going it's robust my enough mentioned it interested the approved in influence what in their then question as in be of but it beginning their multiple amount really technology the for initial to utilization way utilizing call a on get they were is robotics Sure easier it very in. the and accounts which I Young, can your systems the volume remarks so in surgeons in might we is the the and to and all happy programs

Unidentified Analyst

are from I the hospital And or backs helpful. That's was any great. systems had so but administrators? push you Okay, on curious, robotic far just either there successful a launch, very surgeons

David Demski

Just to understand installed terms units. your the of question, you in mean

Unidentified Analyst

the of terms In selling anything like process, or like maybe service or pricing that.

David Demski

into As this to negotiate wanted where bring we've the in I and can that always pricing the to practice you it most think hospital been our we've have be. that, value to things and price demonstrated but is able we issue always keep to the an

Unidentified Analyst

much. Thank All right, you great. so

David Demski

you. Thank

Operator

from question Genuity. Canaccord our And comes Rose, next with Kyle

proceed. may You

Unidentified Analyst

My color halo robotic might on Hi, this Brendon those you accounts current to you of [ph] and dovetail sales at off for that effects, is of to any any seeing to or accounts in then Kyle. are implant your early can robotics in just so just in question actually maybe this arrangements in first that terms of just speak point? tied volume the be terms sticking

David Demski

by am Thanks exactly clarify what not halo effect, could Brendon, understand mean I I you that. sure you

Unidentified Analyst

Yeah, in mean that Excelsius of placing I a the other of you you terms just entire are in pull sure products seeing terms in are accounts in through portfolio? so,

David Demski

the those think that at but don't term the will long bring we point for I do the a were products full guys I the huge technology the obviously can have with over confident to to of is continue long-term. that's that's our to portfolio this the surgeons and about talk able be in I'm advantages cases opportunity work opportunity them in us our and to as robotics practice a real and think compelling

Unidentified Analyst

just can talk Thanks. reps the the degree they And create with road? you each just reps in maybe your and in can what terms to capital down of maybe for and core they other thanks. U.S. another to what Great, interact one spine leads the

David Demski

strong fantastic implant but job result team our we each that with has the is think there from can the to other other be they both group done and leads in a with this way want when experience treefrogs they're comment [ph] are they quick start. companies will for in understand if the and capital generating fantastic you I try guys mix the just groups really together, working for been to I It the

Unidentified Analyst

you. Thank

David Demski

you. Thank

Operator

questions. call your XXXX and participation. With concludes Globus the full-year further for Medical This quarter you no you. fourth Thank

may now disconnect. You Good night.

Globus Medical (GMED) 21 Feb 182017 Q4 Earnings call transcript